Mural Health’s Post

We are honored that Mural Health has been named a finalist for the 2025 SCOPE Summit Participant Engagement Award (PEA), for our work to make clinical trials more accessible and diverse through the Harley Jacobsen Clinical Trial Act. In order to promote a more diverse trial population and drug development process, we need to make it possible for all Americans to participate. The Harley Jacobsen Act is a key step in that mission. Currently, the 110M Americans on a social welfare program are prevented from participating in trials, because those payments are very often mislabeled as taxable income, which threatens to disqualify low-income Americans from receiving government benefits like Medicaid and SNAP. The Harley Jacobsen Act seeks to change this by excluding all payments - to all participants - in all clinical trials from being treated as taxable income. We'll be sharing more about our finalist nomination in the weeks leading up to the 2025 SCOPE Summit (February 3-6 in Orlando), so stay tuned! In the meantime, learn more about the awards here: https://lnkd.in/gs4jAhBq #SCOPEsummit #clinicaltrials #clinicalops #digitalhealth

  • text

To view or add a comment, sign in

Explore topics